Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of SVS20 in Patients with Moderate Bilateral Dry Eye Syndrome
2006-001841-32Phase 2Active
- Sponsor
- TRB Chemedica
- Start
- May 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of sodium hyaluronate in dry eye syndrome (DED) (2 arms), sponsored by TRB Chemedica. Started May 2006; status: active.
02
Drugs
sodium hyaluronate
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on 2006-001841-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001841-32.